vs
BioRestorative Therapies, Inc.（BRTX）与VIEMED HEALTHCARE, INC.（VMD）财务数据对比。点击上方公司名可切换其他公司
VIEMED HEALTHCARE, INC.的季度营收约是BioRestorative Therapies, Inc.的3886.8倍（$76.2M vs $19.6K）。VIEMED HEALTHCARE, INC.净利率更高（7.4% vs -16365.5%，领先16372.9%）。VIEMED HEALTHCARE, INC.同比增速更快（25.5% vs -54.7%）。VIEMED HEALTHCARE, INC.自由现金流更多（$9.7M vs $-2.5M）。过去两年VIEMED HEALTHCARE, INC.的营收复合增速更高（22.7% vs -25.2%）
BioRestorative Therapies, Inc.是一家临床阶段生物技术企业，专注于创新再生医学疗法的研发，核心管线覆盖慢性腰痛、代谢类疾病等未被满足的医疗需求领域，主要面向北美市场，推进细胞类创新候选治疗产品的临床开发工作。
Viemed Healthcare是一家专注于呼吸护理解决方案的医疗科技企业，研发、生产及销售便携式呼吸机、呼吸治疗设备及配套支持服务，覆盖北美、欧洲及亚太核心市场的急症、亚急症及居家护理场景，服务急慢性呼吸系统疾病患者。
BRTX vs VMD — 直观对比
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6K | $76.2M |
| 净利润 | $-3.2M | $5.6M |
| 毛利率 | 91.7% | 57.9% |
| 营业利润率 | -19516.8% | 11.0% |
| 净利率 | -16365.5% | 7.4% |
| 营收同比 | -54.7% | 25.5% |
| 净利润同比 | -96.0% | 30.7% |
| 每股收益（稀释后） | $-0.31 | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $19.6K | $76.2M | ||
| Q3 25 | $11.8K | $71.9M | ||
| Q2 25 | $303.3K | $63.1M | ||
| Q1 25 | $25.0K | $59.1M | ||
| Q4 24 | $43.3K | $60.7M | ||
| Q3 24 | $233.6K | $58.0M | ||
| Q2 24 | $89.1K | $55.0M | ||
| Q1 24 | $35.0K | $50.6M |
| Q4 25 | $-3.2M | $5.6M | ||
| Q3 25 | $-3.0M | $3.5M | ||
| Q2 25 | $-2.7M | $3.2M | ||
| Q1 25 | $-5.3M | $2.6M | ||
| Q4 24 | $-1.6M | $4.3M | ||
| Q3 24 | $-1.1M | $3.9M | ||
| Q2 24 | $-4.0M | $1.5M | ||
| Q1 24 | $-2.2M | $1.6M |
| Q4 25 | 91.7% | 57.9% | ||
| Q3 25 | 10.4% | 57.5% | ||
| Q2 25 | 97.1% | 58.3% | ||
| Q1 25 | 88.4% | 56.3% | ||
| Q4 24 | 92.3% | 59.5% | ||
| Q3 24 | 92.2% | 59.3% | ||
| Q2 24 | 92.7% | 59.8% | ||
| Q1 24 | 100.0% | 58.9% |
| Q4 25 | -19516.8% | 11.0% | ||
| Q3 25 | -31432.3% | 7.8% | ||
| Q2 25 | -1089.8% | 8.1% | ||
| Q1 25 | -19230.1% | 6.5% | ||
| Q4 24 | -6212.8% | 10.6% | ||
| Q3 24 | -979.0% | 9.7% | ||
| Q2 24 | -2770.8% | 6.6% | ||
| Q1 24 | -11740.7% | 4.4% |
| Q4 25 | -16365.5% | 7.4% | ||
| Q3 25 | -25748.1% | 4.9% | ||
| Q2 25 | -875.8% | 5.0% | ||
| Q1 25 | -21359.2% | 4.4% | ||
| Q4 24 | -3778.6% | 7.1% | ||
| Q3 24 | -467.2% | 6.7% | ||
| Q2 24 | -4521.4% | 2.7% | ||
| Q1 24 | -6352.2% | 3.2% |
| Q4 25 | $-0.31 | $0.14 | ||
| Q3 25 | $-0.33 | $0.09 | ||
| Q2 25 | $-0.30 | $0.08 | ||
| Q1 25 | $-0.64 | $0.06 | ||
| Q4 24 | $-0.20 | $0.10 | ||
| Q3 24 | $-0.13 | $0.10 | ||
| Q2 24 | $-0.50 | $0.04 | ||
| Q1 24 | $-0.33 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $13.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $356.7K | $141.5M |
| 总资产 | $4.1M | $199.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $3.0M | $13.5M | ||
| Q3 25 | $4.5M | $11.1M | ||
| Q2 25 | $7.4M | $20.0M | ||
| Q1 25 | $9.1M | $10.2M | ||
| Q4 24 | $10.7M | $17.5M | ||
| Q3 24 | $13.1M | $11.3M | ||
| Q2 24 | $14.7M | $8.8M | ||
| Q1 24 | $16.4M | $7.3M |
| Q4 25 | $356.7K | $141.5M | ||
| Q3 25 | $2.2M | $133.6M | ||
| Q2 25 | $4.8M | $139.7M | ||
| Q1 25 | $6.1M | $134.8M | ||
| Q4 24 | $8.5M | $131.4M | ||
| Q3 24 | $10.0M | $125.0M | ||
| Q2 24 | $10.8M | $119.4M | ||
| Q1 24 | $14.5M | $116.3M |
| Q4 25 | $4.1M | $199.2M | ||
| Q3 25 | $5.6M | $202.4M | ||
| Q2 25 | $8.5M | $184.6M | ||
| Q1 25 | $10.3M | $178.1M | ||
| Q4 24 | $12.3M | $177.1M | ||
| Q3 24 | $14.6M | $169.5M | ||
| Q2 24 | $16.1M | $163.9M | ||
| Q1 24 | $18.0M | $154.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.4M | $18.4M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $9.7M |
| 自由现金流率自由现金流/营收 | -12728.8% | 12.7% |
| 资本支出强度资本支出/营收 | 406.5% | 11.5% |
| 现金转化率经营现金流/净利润 | — | 3.27× |
| 过去12个月自由现金流最近4个季度 | — | $11.9M |
8季度趋势，按日历期对齐
| Q4 25 | $-2.4M | $18.4M | ||
| Q3 25 | $-2.9M | $18.4M | ||
| Q2 25 | $-2.7M | $12.3M | ||
| Q1 25 | $-2.8M | $2.9M | ||
| Q4 24 | $-2.3M | $15.0M | ||
| Q3 24 | $-1.7M | $12.7M | ||
| Q2 24 | $-1.9M | $10.2M | ||
| Q1 24 | $-2.3M | $1.2M |
| Q4 25 | $-2.5M | $9.7M | ||
| Q3 25 | — | $10.7M | ||
| Q2 25 | — | $4.1M | ||
| Q1 25 | $-2.8M | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | $-1.8M | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | -12728.8% | 12.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | -11260.7% | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | -752.6% | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | 406.5% | 11.5% | ||
| Q3 25 | 0.0% | 10.6% | ||
| Q2 25 | 0.0% | 12.9% | ||
| Q1 25 | 145.6% | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | 25.0% | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
